Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/30/2010US20100331406 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/30/2010US20100331405 Methods of Treating Term and Near-Term Neonates Having Hypoxic Respiratory Failure Associated with Clinical or Echocardiographic Evidence of Pulmonary Hypertension
12/30/2010US20100331404 Vector Delivery-Based Microbicides
12/30/2010US20100331403 Compounds and methods for the treatment of cancer
12/30/2010US20100331402 Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
12/30/2010US20100331401 Antimicrobial and antiinflammatory composition
12/30/2010US20100331400 Chromene derivatives and use thereof as hif hydroxylase activity inhibitors
12/30/2010US20100331399 Polyphenol extraction process
12/30/2010US20100331398 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applictions
12/30/2010US20100331397 2-5a analogs and their methods of use
12/30/2010US20100331396 Neostatins
12/30/2010US20100331395 Decoy-containing pharmaceutical compositions and method of using the same
12/30/2010US20100331394 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
12/30/2010US20100331393 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers
12/30/2010US20100331392 Antidotes to antisense compounds
12/30/2010US20100331391 Zap-70 as predictor and modulator of effector function of t cells
12/30/2010US20100331389 Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides
12/30/2010US20100331388 Crystalline Duloxetine Hydrochloride
12/30/2010US20100331387 Lyophilized pharmaceutical compositions
12/30/2010US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
12/30/2010US20100331385 Pyrazole urea derivatives used as kinase inhibitors
12/30/2010US20100331384 Guanidine based compounds
12/30/2010US20100331383 Compounds for the treatment of aids and other viral diseases
12/30/2010US20100331382 Processes of making and using pharmaceutical formulations of antineoplastic agents
12/30/2010US20100331381 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands
12/30/2010US20100331380 Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
12/30/2010US20100331379 Benzamide glucokinase activators
12/30/2010US20100331378 Aminotriazole derivatives as alx agonists
12/30/2010US20100331377 Compositions and methods for wound care
12/30/2010US20100331376 Process for Recovering Flunixin From Pharmaceutical Compositions
12/30/2010US20100331375 Biphenyl compounds useful as muscarinic receptor antagonists
12/30/2010US20100331374 Prolyl hydroxylase inhibitors and methods of use
12/30/2010US20100331373 Drug-containing nanoparticles
12/30/2010US20100331372 Pyridin-2-yl derivatives as immunomodulating agents
12/30/2010US20100331371 Methyl-benzimidazole derivatives
12/30/2010US20100331370 Novel isobenzofuran analogs of sclerophytin A
12/30/2010US20100331369 Therapeutic Agents Useful for Treating Pain
12/30/2010US20100331368 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents
12/30/2010US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
12/30/2010US20100331366 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/30/2010US20100331365 Piperidine derivative
12/30/2010US20100331364 TREATMENT OF HFnEF
12/30/2010US20100331363 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
12/30/2010US20100331362 Treatment method for anemia
12/30/2010US20100331361 Pharmaceutical composition containing alpha-adrenergic receptor antagonist and an anti-muscarinic agent and method of improving lower urinary tract symptoms associated with prostatic hypertrophy
12/30/2010US20100331360 3-substituted sulfonyl piperidine derivative
12/30/2010US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/30/2010US20100331358 Tetrahydrofuropyridones
12/30/2010US20100331357 Pharmaceutical composition
12/30/2010US20100331356 Self-microemulsifying drug delivery systems
12/30/2010US20100331355 Substituted Quinolines for the Treatment of Cancer
12/30/2010US20100331354 Intranasal Opioid Compositions
12/30/2010US20100331353 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
12/30/2010US20100331352 Novel crystalline forms of bosentan
12/30/2010US20100331351 Methods and compositions for treating bacterial infection
12/30/2010US20100331350 Inhibitors of bruton's tyrosine kinase
12/30/2010US20100331349 Use of gamma-aminobutyric acid to mask or reduce an unpleasant flavour impression and preparations containing gamma-aminobutyric
12/30/2010US20100331348 Tropane derivatives useful as pesticides
12/30/2010US20100331347 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
12/30/2010US20100331346 Beta-amino acid derivatives for treatment of diabetes
12/30/2010US20100331345 Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors
12/30/2010US20100331344 Modulators of ATP-Binding Cassette Transporters
12/30/2010US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
12/30/2010US20100331342 Immuno Inhibitory Pyrazolone Compounds
12/30/2010US20100331341 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
12/30/2010US20100331340 Use of aryl piperazine derivatives in manufacturing medicants for treating pain
12/30/2010US20100331339 (1-azinone)-substituted pyridoindoles
12/30/2010US20100331338 Glucokinase Activators
12/30/2010US20100331337 Quercetin-Containing Compositions
12/30/2010US20100331336 Protective effect of high dose folate on mycardial ischemia
12/30/2010US20100331335 Inhibitors of Jun N-Terminal Kinase
12/30/2010US20100331334 Inhibitors of mek
12/30/2010US20100331333 Imidazo [1,2-B] Pyridazine Compounds
12/30/2010US20100331332 Methods for treating drug addiction and improving addiction-related behavior
12/30/2010US20100331331 Therapeutic compositions and the use thereof
12/30/2010US20100331330 Methods and compositions for treating ischemic stroke
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331328 Bicyclylaryl-aryl-amine compounds and their use
12/30/2010US20100331327 7-substituted indirubin-3'oximes and their applications
12/30/2010US20100331326 Inhibitors of CYP 17
12/30/2010US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
12/30/2010US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
12/30/2010US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/30/2010US20100331322 Substituted piperidines as renin inhibitors
12/30/2010US20100331321 Bis-(Sulfonylamino) derivatives for use in therapy
12/30/2010US20100331320 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/30/2010US20100331319 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/30/2010US20100331318 Azatricyclic antibiotic compounds
12/30/2010US20100331317 Benzodiazepine compound and pharmaceutical composition
12/30/2010US20100331316 5-phenyl-lh-benz0 [e] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
12/30/2010US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors
12/30/2010US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/30/2010US20100331311 Galantamine as a neuroprotective drug for retinal ganglion cells
12/30/2010US20100331310 Bicycloamine derivatives
12/30/2010US20100331309 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
12/30/2010US20100331308 Oxazolidinone derivatives
12/30/2010US20100331307 Therapeutic compounds and compositions
12/30/2010US20100331306 Heterocyclic compounds and their uses
1 ... 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 ... 7860